Medicine

Jamie M. Everett, A. Srivastava, J. Misdraji

2017AMERICAN JOURNAL OF SURGICAL PATHOLOGY

DOI: 10.1097/pas.0000000000000759

tlooto Summary

2 patients on combination ipilimumab/nivolumab who developed hepatitis and had fibrin ring granulomas in their liver biopsies are reported.

Abstract

Fibrin ring granulomas are an uncommon finding in liver biopsies although they have been described in liver injury secondary to several infectious and noninfectious entities, most notably Q fever. Immune checkpoint inhibitors are recent advances in cancer therapy, and stimulate the immune system to cause antitumoral effects but may also lead to adverse immune events such as hepatitis and colitis. We report 2 patients on combination ipilimumab/nivolumab who developed hepatitis and had fibrin ring granulomas in their liver biopsies.

Citation format

EVERETT, Jamie M.; SRIVASTAVA, A.; MISDRAJI, J. Fibrin ring granulomas in checkpoint inhibitor-induced hepatitis. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017.